Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.
暂无分享，去创建一个
H. Kantarjian | J. Cortes | P. Jain | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | S. Kornblau | S. O'brien | N. Pemmaraju | A. Ferrajoli | G. González | Evguenia Gachimova | G. Gonzalez